Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

This paper reports on an evaluation of 5 RapidArc optimization approaches vs IMRT. This study includes 11 patients with adenocarcinoma of the prostate. Rectal Normal Tissue Complication Probability is used as a constraint in a dose escalation. RapidArc rectal NTCP's are lower than those of IMRT (p = 0.007). This allows a mean dose escalation of 2.1 Gy([0.7 Gy,3.5 Gy]).

Original publication

DOI

10.1016/j.radonc.2010.01.012

Type

Journal article

Journal

Radiother Oncol

Publication Date

05/2010

Volume

95

Pages

149 - 152

Keywords

Adenocarcinoma, Humans, Male, Prostatic Neoplasms, Radiation Dosage, Radiotherapy Planning, Computer-Assisted, Radiotherapy, Intensity-Modulated